32. Drugs Used to Treat Oral Disorders



Drugs Used to Treat Oral Disorders


Objectives



Key Terms


cold sores (fever blisters) (image) (p. 511)


canker sores (image) (p. 511)


candidiasis (image) (p. 512)


mucositis (image) (p. 512)


plaque (image) (p. 512)


dental caries (image) (p. 512)


tartar (image) (p. 512)


gingivitis (image) (p. 512)


halitosis (image) (p. 512)


xerostomia (image) (p. 512)


dentifrices (image) (p. 516)


mouthwashes (image) (p. 516)


Mouth Disorders


image http://evolve.elsevier.com/Clayton


Common disorders affecting the mouth are cold sores on the lip; canker sores and candidal infections of soft tissues of the tongue, cheeks, and gums; and plaque and calculus affecting the gums and teeth. Xerostomia, or lack of saliva, originates from nonoral causes. Halitosis can arise from oral or nonoral diseases. A much less common problem, but one that causes significant discomfort, is oral mucositis.


Cold sores (fever blisters) are caused by the herpes simplex type 1 virus (herpes simplex labialis) and are most commonly found at the junction of the mucous membrane and the skin of the lips or nostrils, although they can occur inside the mouth, especially affecting the gums and roof of the mouth. It is estimated that at least half of all Americans ages 20 to 40 years have had fever blisters. Most victims were infected before 5 years of age. About half of patients will develop recurrent outbreaks of the lesions, often in the same location, separated by latent periods. The recurrence rate and extent of lesions are highly variable. Patients often predict when an outbreak may occur because of predisposing factors, such as systemic illnesses accompanied by fever, cold (hence the names fever blisters and cold sores), or flu, menstruation, extreme physical stress and fatigue, or sun and wind exposure. Chemotherapy or radiation therapy that depresses the immune system also triggers cold sores.


Patients often report that a flare-up of the sores is preceded by a prodrome of burning, itching, and numbness in the area where the lesion develops. The lesions first become visible as small, red papules that develop into fluid-filled vesicles (blisters) 1 to 3 mm in diameter. Smaller lesions often coalesce into larger lesions. Pain is intense, fever may be present, and increased salivation and mouth odor occur. Often, the glands in the neck are swollen because of the body’s response to infection. Over the next 10 to 14 days, a crust develops over the top of many coalesced, burst vesicles; the base is erythematous. The liquid from the vesicles contains live virus that is contagious if transferred to other people by direct contact (e.g., kissing). If pus develops in the vesicles or under the crust of a cold sore, a secondary bacterial infection may be present and should be evaluated for antibiotic therapy.


Canker sores, also known as recurrent aphthous stomatitis (RAS), affect 20% to 50% of people in the United States. The exact cause is unknown, but precipitating factors appear to be stress and local trauma (e.g., chemical irritation, toothbrush abrasion, irritation from orthodontic braces, biting the inside of the cheeks or lips). The lesions are not viral infections as was once thought and they are not contagious. There appears to be a familial factor, as well as nutritional, emotional, and physiologic factors. They can develop at any age and affect both genders in equal numbers. Canker sores can appear as ulcers 0.5 to 2 cm in diameter on surfaces that are not attached to bone, such as the tongue, gums, or inner lining of the cheeks and lips. The lesion is usually gray to whitish yellow, with an erythematous halo of inflamed tissue surrounding the ulcer crater. Lesions do not form blisters and usually do not grow together. Patients may experience a single lesion or as many as 30 or more at one time. The lesions can be painful and can inhibit normal eating, drinking, talking, and swallowing, as well as oral hygiene. There are usually no swollen lymph glands or fever unless the sore becomes secondarily infected. Most canker sores last 10 to 14 days and heal without scarring.


Candidiasis is a fungal infection caused by Candida albicans, the most common organism associated with oral infections. It is often called “the disease of the diseased” because it appears in debilitated patients and patients taking a variety of medicines. The most common predisposing factors are physiologic (e.g., early infancy, pregnancy, old age), diabetes mellitus, malnutrition, malignancies, and radiation therapy. Medicines that predispose a patient to candidiasis are those that depress defense mechanisms (e.g., immunosuppressants, corticosteroids, cytotoxics, broad-spectrum antibiotics) and those that cause xerostomia (e.g., anticholinergics, antidepressants, antipsychotics, antihypertensives, antihistamines).


There are several forms of candidiasis, but the most common is the acute, pseudomembranous form that is often referred to as thrush. It is characterized by white milk curd–appearing plaques attached to the oral mucosa. These plaques usually can be easily detached, and erythematous, bleeding, sore areas appear beneath them. Thrush is most common in infants, pregnant women, and debilitated patients. Treatment requires local or systemic therapy with antifungal agents, such as nystatin (Mycostatin) suspension, or clotrimazole troches (see discussion of antifungal agents in Chapter 46).


Mucositis (as termed stomatitis) is a general term used to describe a painful inflammation of the mucous membranes of the mouth. It is commonly associated with chemotherapy and radiation therapy. Mucositis develops 5 to 7 days after antineoplastic therapy or radiation therapy has been administered. The sores are erythematous ulcerations intermixed with white patchy mucous membranes. Candidal infections are often present.


Commonly used scales and criteria used to standardize the evaluation of mucositis and therapy include the World Health Organization Oral Mucositis Scale (Table 32-1); the Radiation Therapy Oncology Group (RTOG) Acute Radiation Morbidity Scoring Criteria; the Western Consortium for Cancer Nursing Research (WCCNR) stomatitis staging system; and the National Cancer Institute–Common Toxicity Criteria (NCI-CTC). Mucositis is often a primary complaint associated with cancer therapy because it can diminish a patient’s perception of quality of life. It can be severely debilitating, with pain and difficulty in swallowing, eating, drinking, and talking.



Plaque is the primary cause of most tooth, gum (gingiva), and periodontal disease. Plaque, the whitish yellow substance that builds up on teeth and gum lines around the teeth, is thought to originate from saliva. Plaque forms a sticky meshwork that traps bacteria and food particles. If not removed regularly, it thickens, and bacteria proliferate. The bacteria secrete acids that eat into the enamel of teeth, causing dental caries (cavities). If the plaque is not removed within 24 hours, it begins to calcify, forming calculus, or tartar. The calculus forms a foundation for additional plaque to form, eventually eroding under the gum line and causing inflammation (gingivitis) and periodontal disease.


Halitosis is the term used to describe a very foul mouth odor. A temporary foul odor at certain times is normal in healthy individuals, such as “morning breath” or after eating certain foods (e.g., garlic, onions). Halitosis can also signify an underlying pathologic condition. Halitosis comes from oral and nonoral sources. Nonoral causes of halitosis include sinusitis, tonsillitis, and rhinitis; pulmonary diseases such as tuberculosis or bronchiectasis; and elimination of chemicals from the blood, such as acetone exhaled by patients with diabetic ketoacidosis. Paraldehyde and dimethyl sulfoxide (DMSO) are two medicinal agents excreted primarily through the lungs, which leave a characteristic foul odor to the breath. “Smoker’s breath” caused by cigarette smoking is a fairly common cause of halitosis. Oral causes of halitosis include decaying food particles, plaque-coated tongue and teeth, dental caries, poor oral or denture hygiene, periodontal disease, and xerostomia.


Xerostomia is a condition in which the flow of saliva is either partially or completely stopped. About 20% of those older than 65 years report a change in consistency, a decrease in production, or a discontinuation of salivary flow. Xerostomia causes loss of taste, difficulty in chewing and swallowing food, and difficulty in talking, and it increases tooth decay. Xerostomia can also cause a burning sensation of the tongue, mucositis, and reduce how long dentures can be worn each day. The most common causes of xerostomia are medicines (e.g., anticholinergic agents, diuretics, antidepressants, certain antihypertensive agents), diseases (e.g., diabetes mellitus, depression), and functional conditions (e.g., smoking, mouth breathing).



image Life Span Considerations


Salivary Flow


About 20% of people older than 65 years report a change in consistency, decrease in production, or discontinuation of salivary flow. The most common causes of xerostomia are medicines such as anticholinergic agents, diuretics, and antidepressants, and certain antihypertensive medicines.


Drug Therapy for Mouth Disorders


Cold Sores

The goals of treatment are to control discomfort, allow healing, prevent spread to others, and prevent complications. The cold sore should be kept moist to prevent drying and cracking that may make it more susceptible to secondary bacterial infection. Docosanol (Abreva) is the only U.S. Food and Drug Administration (FDA)–approved product clinically proven to shorten healing time as well as the duration of symptoms such as tingling, pain, burning, and itching. It must be applied five times daily starting at the first sign of outbreak (e.g., tingling, redness, itching). Local anesthetics (e.g., benzocaine, dibucaine, lidocaine) in emollient creams, petrolatum, or protectants (e.g., Zilactin B [benzocaine 10%, hydroxypropyl cellulose, propylene glycol, alcohol 70%]) can temporarily relieve the pain and itching and prevent drying of the lesion.


Topical analgesics (e.g., Blistex [dimethicone, menthol, camphor, phenol]) are safe and effective for temporarily reducing pain. Oral analgesics (e.g., aspirin, acetaminophen, ibuprofen, naproxen) may also provide significant pain relief. Broad-brimmed hats and ultraviolet blockers (e.g., Chapstick Lip Moisturizer Ultra, Natural Ice) with a sun protection factor (SPF) of at least 15 can be used for patients whose cold sores occur with sun exposure. Secondary infections can be treated with a topical antibiotic ointment such as Neosporin.


Canker Sores

The goals of treatment are similar to those for cold sores, to control discomfort and promote healing. Topical amlexanox paste 5% (Aphthasol) is an anti-inflammatory agent that hastens healing when compared with placebo. The paste should be applied to each lesion as soon as possible after noting the symptoms of a canker sore. The patient should continue to use the paste four times daily, preferably following oral hygiene after breakfast, lunch, and dinner and at bedtime.


Protectants such as hydroxypropyl cellulose film (Zilactin) may reduce friction. Topical anesthetics to control discomfort, such as benzocaine (Kank-A [benzocaine 20% in oral mucosal protectant]), are particularly effective if applied just before eating or performing oral hygiene. Oral analgesics (e.g., aspirin, acetaminophen, ibuprofen, naproxen) may also provide significant pain relief. Aspirin should not be placed on the lesions because of the high risk of severe chemical burns, with necrosis.


Oxygen-releasing agents (carbamide peroxide [Gly-Oxide], hydrogen peroxide [Colgate Peroxyl]) can be used as débriding and cleansing agents up to four times daily for 7 days. Long-term safety has not been established, and tissue irritation and black hairy tongue have been reported. Saline rinses (1 to 3 teaspoons of table salt) in 4 to 8 ounces of warm tap water may be soothing and can be used before topical application of medication. Sustained use of products containing menthol, phenol, camphor, and eugenol should be discouraged because they cause tissue irritation and damage or systemic toxicity if overused. Silver nitrate should not be used to cauterize lesions because it may damage healthy tissue surrounding the lesion and predispose the area to later infection.


Mucositis

Basic oral hygiene is an important component of care for any patient with cancer. The purpose is to decrease the complications associated with pain, oral microorganisms, and bleeding. Prior to cancer therapy, a baseline pretreatment oral mucosal assessment should be completed to rule out pre-existing conditions or infections that might aggravate impending mucositis. Although it takes 5 to 7 days for mucositis to develop after a patient begins chemotherapy or radiation therapy, oral hygiene regimens should be started when chemotherapy or radiation therapy is initiated. Oral hygiene, oral irrigations, and methods to relieve dry mouth and lips can be very effective in providing comfort.


Pain associated with oral mucositis can be a major complication that contributes to poor nutrition and hydration. To be effective, topical applications of medications for pain must come into contact with the tissue. Therefore, it is advisable to schedule these routines immediately after cleaning the oral cavity. In addition to the previously described protectants, local anesthetics, and analgesics, the following are routine approaches to treating pain in the oral area:



• Viscous lidocaine 2% can be used before meals to relieve pain. Frequent applications are required, and the sense of taste is diminished. Care must be taken to make sure the patient is not burned by the food because the entire mouth and throat are anesthetized.


• Milk of magnesia can be used to rinse the mouth and coat the mucous membranes.


• Nystatin liquid suspension can be swished in the mouth for 1 minute and then swallowed (swish and swallow routine), or clotrimazole lozenges may be dissolved slowly in the mouth and then swallowed to reduce candidal oral infections.


• Sucralfate suspensions applied topically have been reported to provide effective pain relief.


• Oral or parenteral analgesics (e.g., morphine) should be administered for severe pain.


• A new medicine—recombinant human keratinocyte growth factor, palifermin (Kepivance)—has been approved specifically for stimulating epithelial cell proliferation to prevent or treat the mucositis that develops in hematologic malignancies in patients undergoing chemotherapy before bone marrow transplantation.

< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 11, 2016 | Posted by in NURSING | Comments Off on 32. Drugs Used to Treat Oral Disorders

Full access? Get Clinical Tree

Get Clinical Tree app for offline access